Tapewire

Nasdaq · USD

ANAB

ANAPTYSBIO, INC

Export transactions ↓
Tapewire entity
4640
SEC CIK
0001370053
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 42 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 2026017
Feb 202601
Mar 2026013
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 22, 2024 Filed Jul 24, 2024 20:15 UTC
Lizzul Paul F.Chief Medical Officer
GrantCommon Stock · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-020036 · form4-07242024_080712.xml · derivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

F2 · derivative.expiration_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 20:15 UTC
Faga DanielDirector · CEO
GrantCommon Stock · Derivative 160,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-020039 · form4-07242024_080744.xml · derivative · entry 1

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

F2 · derivative.expiration_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 16:13 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
GrantCommon Stock · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-020031 · form4-07242024_080748.xml · derivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

F2 · derivative.expiration_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 20:14 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
GrantCommon Stock · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-020034 · form4-07242024_080733.xml · derivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

F2 · derivative.expiration_date: Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026. An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date.

Read SEC document
July 18, 2024 Filed Jul 20, 2024 00:35 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon · Derivative 1,500 $0.00 Strike: $18.50 $0.00
Disclosure

SEC source: 0001415889-24-019829 · form4-07202024_120740.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,500

Underlying: Common · 1,500 shares

Expires 2030-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 31, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F4 · balance_after: In addition to the remaining options to purchase 88,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 297,610 shares of common stock, which options vest according to their terms.

Read SEC document
July 18, 2024 Filed Jul 20, 2024 00:35 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 1,500 $35.00 $52,500.00
Disclosure

SEC source: 0001415889-24-019829 · form4-07202024_120740.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,618

F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2023.

Read SEC document
July 18, 2024 Filed Jul 20, 2024 00:35 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 1,500 $18.50 $27,750.00
Disclosure

SEC source: 0001415889-24-019829 · form4-07202024_120740.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the acquisition of 1,500 shares acquired under the Company's ESPP.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:45 UTC Exercise / conversionCommon Stock · Derivative 10,000 $0.00 Strike: $6.93 $0.00
Disclosure

SEC source: 0001415889-24-019676 · form4-07172024_080731.xml · derivative · entry 4

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,925

Underlying: Common Stock · 10,000 shares

Expires 2025-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:45 UTC SaleCommon Stock 2,897 $30.98 $89,753.98
Disclosure

SEC source: 0001415889-24-019676 · form4-07172024_080731.xml · nonDerivative · entry 3

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,950

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.92 to $31.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:45 UTC SaleCommon Stock 7,103 $30.50 $216,668.49
Disclosure

SEC source: 0001415889-24-019676 · form4-07172024_080731.xml · nonDerivative · entry 2

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,847

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.91 to $30.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:45 UTC Exercise / conversionCommon Stock 10,000 $6.93 $69,300.00
Disclosure

SEC source: 0001415889-24-019676 · form4-07172024_080731.xml · nonDerivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 21, 2024 Filed Jun 24, 2024 21:23 UTC SaleCommon Stock 1,950 $23.17 $45,181.50
Disclosure

SEC source: 0001415889-24-018032 · form4-06242024_090611.xml · nonDerivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,950

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024.

Read SEC document
June 18, 2024 Filed Jun 19, 2024 00:15 UTC SaleCommon Stock 1,950 $23.16 $45,162.00
Disclosure

SEC source: 0001415889-24-017507 · form4-06192024_120659.xml · nonDerivative · entry 2

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,950

F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:16 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017509 · form4-06192024_120621.xml · derivative · entry 2

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:16 UTC Exercise / conversionCommon Stock 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017509 · form4-06192024_120621.xml · nonDerivative · entry 1

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:17 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017510 · form4-06192024_120656.xml · derivative · entry 2

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:17 UTC Exercise / conversionCommon Stock 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017510 · form4-06192024_120656.xml · nonDerivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:15 UTC
Orwin John ADirector
Exercise / conversionRestricted Stock Unit · Derivative 2,035 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017508 · form4-06192024_120637.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,035 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:15 UTC
Orwin John ADirector
Exercise / conversionCommon Stock 2,035 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017508 · form4-06192024_120637.xml · nonDerivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:18 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017512 · form4-06192024_120627.xml · derivative · entry 2

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:18 UTC Exercise / conversionCommon Stock 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017512 · form4-06192024_120627.xml · nonDerivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:15 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017507 · form4-06192024_120659.xml · derivative · entry 3

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:15 UTC Exercise / conversionCommon Stock 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017507 · form4-06192024_120659.xml · nonDerivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:17 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017511 · form4-06192024_120639.xml · derivative · entry 2

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:17 UTC Exercise / conversionCommon Stock 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017511 · form4-06192024_120639.xml · nonDerivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:14 UTC
Jain RitaDirector
Exercise / conversionRestricted Stock Unit · Derivative 1,300 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017506 · form4-06192024_120600.xml · derivative · entry 3

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.

F3 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:14 UTC
Jain RitaDirector
Exercise / conversionRestricted Stock Unit · Derivative 3,234 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017506 · form4-06192024_120600.xml · derivative · entry 2

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,234 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2024 Filed Jun 19, 2024 00:14 UTC
Jain RitaDirector
Exercise / conversionCommon Stock 4,534 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-017506 · form4-06192024_120600.xml · nonDerivative · entry 1

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
May 22, 2024 Filed May 24, 2024 20:12 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,500 $23.72 $35,580.00
Disclosure

SEC source: 0001415889-24-014463 · form4-05242024_080509.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 964

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2023.

F2 · balance_after: Includes shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan, for the purchase period through May 15, 2024.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 00:10 UTC
Faga DanielDirector · CEO
Tax withholdingCommon Stock 347,441 $21.60 $7,504,725.60
Disclosure

SEC source: 0001415889-24-009164 · form4-03272024_120311.xml · nonDerivative · entry 3

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 401,646

F2 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 00:10 UTC
Faga DanielDirector · CEO
SaleCommon Stock 3,000 $21.42 $64,267.50
Disclosure

SEC source: 0001415889-24-009164 · form4-03272024_120311.xml · nonDerivative · entry 2

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 749,087

F1 · kind: Represents shares sold by the Reporting Person to cover a portion of the tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by "sell to cover transactions" and do not represent discretionary transactions by the Reporting Person.

F2 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
March 22, 2024 Filed Mar 27, 2024 00:10 UTC
Faga DanielDirector · CEO
SaleCommon Stock 145,940 $22.78 $3,325,184.52
Disclosure

SEC source: 0001415889-24-009164 · form4-03272024_120311.xml · nonDerivative · entry 1

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 752,087

F1 · kind: Represents shares sold by the Reporting Person to cover a portion of the tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by "sell to cover transactions" and do not represent discretionary transactions by the Reporting Person.

F2 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:38 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $14.02 $0.00
Disclosure

SEC source: 0001415889-24-004666 · form4-02212024_100259.xml · derivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,000

Underlying: Common Stock · 5,000 shares

Expires 2029-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

F3 · balance_after: In addition to the remaining options to purchase 78,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 355,310 shares of common stock, which options vest according to their terms.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:38 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 5,000 $25.00 $125,000.00
Disclosure

SEC source: 0001415889-24-004666 · form4-02212024_100259.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,240

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated September 15, 2023.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:38 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 5,000 $14.02 $70,100.00
Disclosure

SEC source: 0001415889-24-004666 · form4-02212024_100259.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,240

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 30, 2024 Filed Feb 1, 2024 22:27 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
SaleCommon Stock 3,065 $23.63 $72,425.34
Disclosure

SEC source: 0001415889-24-002204 · form4-02012024_100227.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 964

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.325 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 00:08 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 2,554 $21.81 $55,702.74
Disclosure

SEC source: 0001209191-24-001280 · doc4.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,118

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 00:05 UTC
Faga DanielDirector · CEO
SaleCommon Stock 6,866 $21.81 $149,747.46
Disclosure

SEC source: 0001209191-24-001277 · doc4.xml · nonDerivative · entry 2

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 898,027

F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 08, 2024 Filed Jan 9, 2024 19:07 UTC
LOUMEAU ERIC JChief Legal Officer
SaleCommon Stock 2,305 $21.81 $50,272.05
Disclosure

SEC source: 0001209191-24-001279 · doc4.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,240

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 00:06 UTC
MULROY DENNISChief Financial Officer
SaleCommon Stock 2,180 $21.81 $47,545.80
Disclosure

SEC source: 0001209191-24-001278 · doc4.xml · nonDerivative · entry 2

MULROY DENNIS · CIK 0001276840 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,029

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 06, 2024 Filed Jan 10, 2024 00:08 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 6,145 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001280 · doc4.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,435

Underlying: Common Stock · 6,145 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2024 Filed Jan 10, 2024 00:08 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 6,145 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001280 · doc4.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,672

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2024 Filed Jan 10, 2024 00:05 UTC
Faga DanielDirector · CEO
Exercise / conversionRestricted Stock Unit · Derivative 17,850 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001277 · doc4.xml · derivative · entry 3

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,550

Underlying: Common Stock · 17,850 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2024 Filed Jan 10, 2024 00:05 UTC
Faga DanielDirector · CEO
Exercise / conversionCommon Stock 17,850 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001277 · doc4.xml · nonDerivative · entry 1

Faga Daniel · CIK 0001673528 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 904,893

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · balance_after: Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.

Read SEC document
January 06, 2024 Filed Jan 9, 2024 19:07 UTC
LOUMEAU ERIC JChief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 5,545 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001279 · doc4.xml · derivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,635

Underlying: Common Stock · 5,545 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2024 Filed Jan 9, 2024 19:07 UTC
LOUMEAU ERIC JChief Legal Officer
Exercise / conversionCommon Stock 5,545 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001279 · doc4.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2024 Filed Jan 10, 2024 00:06 UTC
MULROY DENNISChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 5,245 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001278 · doc4.xml · derivative · entry 3

MULROY DENNIS · CIK 0001276840 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,735

Underlying: Common Stock · 5,245 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2024 Filed Jan 10, 2024 00:06 UTC
MULROY DENNISChief Financial Officer
Exercise / conversionCommon Stock 5,245 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001278 · doc4.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:51 UTC GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001043 · doc4.xml · derivative · entry 2

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:51 UTC GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $21.19 $0.00
Disclosure

SEC source: 0001209191-24-001043 · doc4.xml · derivative · entry 1

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.